← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

EVP and General Counsel Paul A Mahon sold $4.1M of United Therapeutics Corporation

Sold$4,129,608
$497.54Price
8,300Shares
−16%Stake

What UTHR did after the filing

Filed Sep 18Copier in Sep 21
The stock from Mon, Sep 21 open, $497.70
+9.1%
S&P 500, same days
0.0%

20 of 30 trading days so far, to the Oct 19 close.

Traded Thu, Sep 17. Filed Fri, Sep 18, 4:40 PM ET, after the close. Returns use the Sep 21 open and the Oct 19 close. Not investment advice.